Related by context. Frequent words. (Click for all words.) 72 Nanobody 69 therapeutic monoclonal antibodies 69 Vaccinex 68 R sorafenib tablets 68 Syntonix 68 Argatroban 67 HepeX B 67 Panzem R 67 www.vivus.com 67 GRNVAC1 67 Initiates Phase II 66 novel antibody therapeutics 66 StromaCel Inc. 66 JAK inhibitor 66 HCV protease inhibitor 66 TLR9 agonists 66 Aegera 65 ZFP Therapeutics 65 Galenea 65 MEK inhibitors 65 Loramyc R 65 GVAX cancer 65 Panzem R NCD 65 www.syntapharma.com 65 PLK1 SNALP 65 elotuzumab 65 Shigamabs ® 65 Inotek 65 PEG SN# 65 Prodarsan ® 65 Hybridon 65 deforolimus 65 Fortical R 65 inflammatory autoimmune diseases 65 AZX# 64 novel RNAi therapeutics 64 Celator 64 Idera Pharmaceuticals 64 GVAX R 64 Taiho Pharmaceutical 64 forodesine 64 ATL# [001] 64 investigational therapies 64 Inc Therapeutic Competitors 64 theranostic 64 immunotherapeutics 64 Cetrorelix 64 Nasdaq OSIP 64 developing Zerenex TM 64 orthobiologic 64 Chrysalin 64 Euroscreen 64 BiTE R 64 pradefovir 64 PsychoGenics 64 www.BMRN.com 64 Prestara 64 nitric oxide donating 64 Kuvan R 64 Currently RegeneRx 64 NOXXON 64 Nanobodies 64 multi kinase inhibitor 64 faropenem 64 CDP# 64 Canvaxin 64 Copegus R 63 Factor VIIa 63 Tarvacin TM 63 AEG# 63 KNS # 63 liposomal formulation 63 MultiCell Technologies 63 Inc. Nasdaq IMGN 63 Hematide TM 63 Rotarix R 63 Aurexis 63 CCX# 63 L BLP# 63 CMV vaccine 63 Ixempra 63 Ketotransdel 63 ALN VSP 63 Omigard TM 63 Mpex 63 REGN# 63 VEGFR2 inhibitor 63 www.polymedix.com 63 TLR9 agonist 63 proteasome inhibitor 63 immunological diseases 63 refractory chronic lymphocytic 63 topical anti infective 63 leading lipid nanoparticle 63 Oncaspar 63 Tibotec Pharmaceuticals Ltd. 63 Chemokine Therapeutics 63 Phase Ib IIa 63 outlicensing 63 Scancell 62 JAK3